Company Profiles

driven by the PitchBook Platform

Avizorex Pharma

Description

Developer of drugs for ophthalmic treatment. The company engages in research and development of therapeutic drugs for the treatment of dry eye syndrome.

2013

Founded

PRIVATE

Status

Series A

Latest Deal Type

$3.17M

Latest Deal Amount

$3.17M

Total Amount Raised

2

Investors

Description

Developer of drugs for ophthalmic treatment. The company engages in research and development of therapeutic drugs for the treatment of dry eye syndrome.

Website:

www.avizorexpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

c/Baldiri Reixac 4-8 08028 BarcelonaSpain +34 93 402 902
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avizorex Pharma's full profile, request a free trial.

Avizorex Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avizorex Pharma Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ENISAGovernmentMinority000 0000000 0000
Inveready Technology Investment GroupVenture CapitalMinority000 0000000 0000
ENISA Government
Inveready Technology Investment Group Venture Capital

Avizorex Pharma Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Patrick TresserrasCo-Founder, President, Chief Executive Officer & Board Member
Jordi Petit SalamoChief Financial Officer
Carlos Belmonte Ph.DCo-Founder
Patrick Tresserras Co-Founder, President, Chief Executive Officer & Board Member
Jordi Petit Salamo Chief Financial Officer
Carlos Belmonte Ph.D Co-Founder

Avizorex Pharma Board Members (3)

NameRepresentingRoleSinceContact
Info
Patrick TresserrasAvizorex PharmaCo-Founder, President, Chief Executive Officer & Board Member000 0000
Roger Piqué PijuanInveready Technology Investment GroupGeneral Partner000 0000
Sara SecallInveready Technology Investment GroupPrincipal000 0000
Patrick Tresserras Co-Founder, President, Chief Executive Officer & Board Member Avizorex Pharma
Roger Piqué Pijuan General Partner Inveready Technology Investment Group
Sara Secall Principal Inveready Technology Investment Group
Request full access to PitchBook